|
|
| MRD / Regn No. |
: THBC\23-24\08971 |
Date |
: 09/07/2026 |
| Patient Name |
: Devendra Shinde |
Age & Gender |
: 45 Yrs. / Male |
| Contact No. |
: 9920825034 |
UHID |
: |
| Ht / Wt / BMI |
: 165 / 97.65 / 35.87 |
BP S / BP D |
: 124 / 80 |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM (26/Mar/2024) | HYPOTHYROIDISM (26/Feb/2019) | DYSLIPIDEMIA (26/Mar/2026) | |
|
Subjective |
: |
HYPOTHYROIDISM SINCE 2019,DYSLIPIDEMIA MAR 26,T2DM SINCE 2024- WAS GDM / BIRTH WEIGHT 3 KGS,RULED OUT ACROMEGALY,DID NOT TOLERATE 0.25 MG ONE PARTICULAR DOSE - STEPPED DOWN TO 0.25 MG 1/2 DOSE X 3 DOSES - TOLERATING WELL,SO INCR TO 0.25 FULL DOSE X 4 DOSES - IF OK CAN INCREASE TO 0.5 MG WEEKLY,COMES HOME LATE - DIFFICULTY IN TAKING BEFORE FOOD,LOST 2 KGS WT BUT REGAINED AS DOSE REDUCED AND ATE LOT OF MANGOES |
|
Objective |
: |
08-JUL-2026 REPORTS,HB-14.9/ HBA1C-8.1%,FBS-186,ALT-59/ AST-39,CR-0.87,EGFR-108.42,TC-156/ TG-138/ LDL-92.4/ HDL-36,T3-57.9/ T4-4/ TSH-4.5565 |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET THYROXINE SODIUM 75 MCG
THYRONORM 75 MCG |
ORAL |
1-0-0 |
BBF
|
3 MTHS |
|
|
2 |
STORVAS 10MG |
ORAL |
0-0-1 |
AD
|
3 MTHS |
|
|
3 |
TABLET DOMPERIDONE (30MG) + ESOMEPRAZOLE (40MG)
NEXPRO RD 40 MG |
ORAL |
SOS |
|
30 DAYS |
|
|
4 |
UPRISE D3 60 K |
ORAL |
1 TAB ONCE A WEEK |
ANY TIME OF DAY
|
3 MTHS |
|
|
5 |
INJ OZEMPIC 0.25 MG |
SC |
1/WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
6 |
INJ OZEMPIC 0.5 MG |
SC |
0.5 MG / WEEK |
ANYTIME OF DAY
|
4 WEEKS |
|
|
7 |
INJ OZEMPIC 1 MG |
SC |
1/WEEKLY |
ANYTIME OF DAY
|
4 WEEKS |
|
|
8 |
LIPAGLYN / VORAXAR / BILYPSA 4 |
ORAL |
0-0-1 |
AD
|
3 MTHS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.,IF LOW SUGARS (<70 MG/DL) |
| Next Visit |
: 09/Oct/2026 |
| Tests Suggested For Next Visit |
: HBA1C / FBS + URINE FOR ALBUMIN:CREAT RATIO / TSH > 3 MTHS |
| |
|
| |
|
|
